ArticleJournal of nanobiotechnology2026

Tumor-activated dual metabolic nanomodulator turns over tolerogenic tumor control and unleashes systemic immune responses.

Xiaorong Kou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.